Advancing a Brain-Targeted AAV Gene Therapy for Alzheimer’s Disease
Time: 9:00 am
day: Day One - Morning
Details:
- Evaluating functional RNA silencing in the brain
- Advancing brain-targeted viral vector design
- Exploring the path from preclinical success to clinical impact
